Effect of acupuncture-moxibustion on TNF-α, sTNFR-I and sTNFR-II of rats with Crohn's disease

Journal of Acupuncture and Tuina Science

Volumn 7, Issue 1, 2009, Pages 29-32

  Shi, Zheng ^a   Ma, Xiao Peng ^a   Wu, Huan Gan ^a   Qin, Xiu Di ^a   Qian, Qing Lan ^a   Zhang, Wei ^a  

^a SHANGHAI RESEARCH INSTITUTE OF ACUPUNCTURE AND MERIDIAN   (China)

Author keywords

Acupuncture moxibustion therapy; Crohn's disease; Rats; Receptors; Tumor necrosis factor; Tumor necrosis factor alpha; Type I; Type II

Indexed keywords

EID: 58149201031     PISSN: 16723597     EISSN: 19930399     Source Type: Journal    
DOI: 10.1007/s11726-009-0029-4     Document Type: Article

References (6)

1. WU Huan-gan, ZHANG Lin-shan. Clinical Study of Herbs-partition Moxibustion on Crohn's Disease. Modern Rehabilitation, 2000, 4(3): 397.
2. Morris GP, Beck Pl, Herridge MS, et al. Hapten-induced Model of Chronic Inflammation and Ulceration in the Rat Colon. Gastroenterology,1989, 96(3): 95-811.
3. DENG Chang-sheng, XIA Bing. Inflammatory Bowel Diseases. Beijing: People's Medical Publishing House, 1998: 123.
4. Colombel JF, Loftus EV Jr, Tremaine WJ, et al. The Safety Profile of Infliximab in Patients with Crohn's Disease: The Mayo Clinic Experience in 500 Patients. Gastroenterology, 2004, 126(1):19-31.
5. Hanauer SB, Feagan BG, Lichtenstein GR, et al. Maintenance Infliximab for Crohn's Disease: The ACCENT I Randomised Trial, Lancet, 2002, 359(9317):1541-1549.
6. Aliprantis AO, Diez-Roux G, Mulder LC, et al. Do Amacrophages Kill Though Apoptosis. Immunol Today, 1996, 17(12): 573-578.